Gastroesophageal Reflux Disease
📧 Sign up to get email alerts when something new happens for Gastroesophageal Reflux Disease.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2024-11-12FDA Approved: ESOMEPRAZOLE MAGNESIUM — Supplemental Application (Mylan Pharmaceuticals Inc.)
FDA approved a supplemental application for esomeprazole magnesium from Mylan Pharmaceuticals, enabling the generic product to be marketed w…
-
FDA approval · 2024-11-12FDA Approved: CIMETIDINE — Original Application (Aurobindo Pharma Limited)
FDA approves Aurobindo Pharma Limited's original application for cimetidine (generic cimetidine), authorizing its marketing as a generic H2 …
-
FDA approval · 2024-11-08FDA Approved: GOOD NEIGHBOR PHARMACY OMEPRAZOLE — Supplemental Application (Amerisource Bergen)
FDA approved a supplemental application for Good Neighbor Pharmacy Omeprazole (omeprazole) submitted by Amerisource Bergen.
-
FDA approval · 2024-11-08FDA Approved: ACID REDUCER — Supplemental Application (WALGREEN CO.)
FDA approves a supplemental application for ACID REDUCER (omeprazole) from Walgreens Co., under ANDA206877.
-
FDA approval · 2024-11-07FDA Approved: CIMETIDINE — Original Application (Bionpharma Inc.)
FDA approved Bionpharma Inc.'s Original Application for cimetidine, enabling the marketing of a generic H2 blocker. The action establishes a…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2024-11-05FDA Approved: RABEPRAZOLE SODIUM — Supplemental Application (Amneal Pharmaceuticals LLC)
FDA approved a supplemental application for rabeprazole sodium (Amneal Pharmaceuticals LLC).
-
FDA approval · 2024-11-04FDA Approved: LANSOPRAZOLE — Original Application (Macleods Pharmaceuticals Limited)
FDA approved a generic version of lansoprazole via an Original Abbreviated New Drug Application for Macleods Pharmaceuticals Limited.
-
CLINICAL_TRIALS research · 2024-10-30Clinical Trial Update: Sleeve-pex: A Randomized Trial to Reduce Reflux After Sleeve Gastrectomy [NA]
Sleeve-pex is a randomized trial to reduce reflux after sleeve gastrectomy. It is currently recruiting.
-
CLINICAL_TRIALS research · 2024-10-29Clinical Trial Update: The Effect of Probiotic and Zinc Supplementation in Patients With Gastroesophageal Reflux Disease [Phase 4]
Phase 4 clinical trial update on probiotic and zinc supplementation for gastroesophageal reflux disease. The study is currently not yet recr…
-
FDA approval · 2024-10-23FDA Approved: ESOMEPRAZOLE — Original Application (Macleods Pharmaceuticals Limited)
FDA approved Esomeprazole under an Original Application for Macleods' generic product, enabling generic market access.
-
CLINICAL_TRIALS trial_result · 2024-10-23Clinical Trial Update: Usefulness of Wireless pH Monitoring in GERD Diagnosis
This completed clinical trial evaluates the usefulness of wireless pH monitoring for diagnosing gastroesophageal reflux disease.
-
CLINICAL_TRIALS trial_result · 2024-10-23Clinical Trial Update: Domiciliary Management of Dental Erosion in Patients With GERD With Biomimetic Hydroxyapatite [NA]
A completed clinical trial from the University of Pavia evaluated home-based management of dental erosion in patients with gastroesophageal …
-
CLINICAL_TRIALS trial_result · 2024-10-15Clinical Trial Update: EndoStim Patient Registry
EndoStim Inc.'s GERD patient registry (NCT02441400) has been terminated.
-
CLINICAL_TRIALS research · 2024-09-27Clinical Trial Update: The Influence of Concomitant Irritable Bowel Syndrome on Gastro-Oesophageal Reflux Disease Symptoms and Severity.
This clinical trial update investigates whether concomitant irritable bowel syndrome influences the symptoms and severity of gastroesophagea…
-
CLINICAL_TRIALS trial_result · 2024-09-19Clinical Trial Update: Transition to Infant Formula Feeding on Gastrointestinal Regurgitation (TIGER) Study [NA]
The TIGER study, sponsored by Dairy Goat Co-operative (New Zealand), completed a clinical trial evaluating transition to infant formula feed…
-
CLINICAL_TRIALS trial_result · 2024-09-19Clinical Trial Update: Dietary Carbohydrate and GERD in Veterans [NA]
This VA-sponsored clinical trial assessed the impact of dietary carbohydrate on gastroesophageal reflux disease and obesity in veterans. Res…
-
CLINICAL_TRIALS other · 2024-09-19Clinical Trial Update: Management of Obese Patients With Gastroesophageal Reflux Disease . [NA]
This document updates a clinical trial investigating management of obesity in patients with gastroesophageal reflux disease, which is not ye…
-
FDA label_change · 2024-09-16FDA Approved: LANSOPRAZOLE — Supplemental Application (Zydus Pharmaceuticals USA Inc.)
The FDA approved a supplemental application for lansoprazole from Zydus Pharmaceuticals USA Inc., resulting in updated labeling for the prod…
-
CLINICAL_TRIALS research · 2024-08-21Clinical Trial Update: The Effect of Postural Correction On Gastroesophageal Reflux Disease [NA]
A Cairo University-sponsored clinical trial is evaluating whether postural correction can affect gastroesophageal reflux disease, and the st…
-
FDA approval · 2024-08-20FDA Approved: FAMOTIDINE — Supplemental Application (Baxter Healthcare Corporation)
FDA approved Baxter Healthcare Corporation's supplemental application for famotidine (ANDA075591), granting approval for the generic product…
-
CLINICAL_TRIALS research · 2024-08-15Clinical Trial Update: Indiana University Gastrointestinal Motility Diagnosis Registry
Indiana University has launched a Gastrointestinal Motility Diagnosis Registry on ClinicalTrials.gov, currently recruiting to collect data a…
-
CLINICAL_TRIALS trial_result · 2024-08-14Clinical Trial Update: Comparative Pharmacodynamics and Pharmacodynamics Equivalence of Antareit 800 mg Chewable Tablets and Riopan 800 mg Chewable Tablets in Healthy Volunteers [NA]
This completed study evaluated whether Antareit 800 mg chewable tablets are pharmacodynamically equivalent to Riopan 800 mg chewable tablets…
-
CLINICAL_TRIALS trial_result · 2024-08-12Clinical Trial Update: FODMAPs and Refractory GERD [NA]
The trial evaluating the role of a FODMAP-containing diet in patients with refractory gastroesophageal reflux disease has completed. This up…
-
FDA approval · 2024-08-06FDA Approved: FAMOTIDINE — Original Application (Novadoz Pharmaceuticals LLC)
FDA approved the original ANDA application for famotidine from Novadoz Pharmaceuticals LLC, enabling a generic version of famotidine to reac…
-
CLINICAL_TRIALS withdrawal · 2024-08-05Clinical Trial Update: Transoral Incisionless Fundoplication (TIF) for Laryngopharyngeal Reflux (LPR) Patients
The clinical trial evaluating Transoral Incisionless Fundoplication (TIF) for laryngopharyngeal reflux and GERD has been withdrawn.